Campari Group S.p.A. (BIT: CPR) reports H1-2026 organic net sales growth of more than 2.0% year-on-year (expected approx. July 31, 2026)
Hit
✦ AI-generated prediction
Published on 21. July 2026
·
Predicted for 31. July 2026
·
Based on: Historical Cycle
Campari Group (Aperol, Campari, Wild Turkey, Espolòn) recorded approx. –4% organic in H1 2025 but turned positive in H2 2025. Aperol price increases of ~+5% in Europe (since January 2026), recovery in the US tequila segment (Espolòn), and first-time consolidation of the Bailey acquisition support H1-2026 growth. Sector comparison: AB InBev organic +4%, Pernod Ricard guidance –3% to –4%. Campari is positioned for moderate mid-tier recovery. No prediction market quote; own calibration 55%.
Data basis for this prediction
- Campari Group FY2025: H2 2025 organisches Wachstum positiv (Campari IR, Feb. 2026)
- Aperol Preiserhöhung Europa +5 % seit Januar 2026 (Reuters, Jan. 2026)
- AB InBev H1-2026 Konsens: organisch +4 % YoY (Bloomberg Consensus, Juli 2026)
- CPR H1-Meldetermin: ca. 31. Juli 2026 (Campari Group Investor Relations Kalender)
Verdict: Hit
Campari Group meldete für H1 2026 ein organisches Nettoumsatzwachstum von +2,7 % (Q2 isoliert +2,5 %), was die Schwelle von >2,0 % klar übertrifft. Treiber waren die 'House of Aperitifs'-Marken (Aperol +3,3 %, Campari +2,3 %) sowie Espolòn. Die Ergebnisse wurden am 29. Juli 2026 veröffentlicht – nahezu exakt zum erwarteten Termin 31. Juli 2026. Der bereinigte EBIT stieg organisch +8,5 %, die Jahreszielgröße wurde auf ~3 % organisches Wachstum bestätigt. Quellen: The Spirits Business (https://www.thespiritsbusiness.com/2026/07/campari-h1-sales-up-2-7-as-it-divests-brands/), Campari Group Half-Year Report 30 June 2026 (https://www.camparigroup.com/sites/default/files/downloads/01.1_Campari%20Group_Half%20year%20report%20at%2030%20June%202026.pdf), Investing.com Earnings Call Transcript (https://www.investing.com/news/transcripts/earnings-call-transcript-campari-posts-steady-h1-growth-in-q2-2026-93CH-4821435).
🍾 Beverages
✦ AI
Rémy Cointreau published its H1 FY2026/27 result on October 27, 2026: organic growth of +2.9 percent YoY for April–September 2026 — 90 basis points above this forecast's threshold. The company confirmed its FY2026/27 guidance ('gradual return to organic growth'). Q2 FY2026/27 (Jul–Sep): Cognac up 12 percent YoY. FY2025/26 full year: +0.2 percent organic ('in line with targets', Rémy IR, June 3, 2026). Achieving above 2.0 percent for the full year only requires H2 (Oct 2026–Mar 2027) to avoid a complete collapse — the 90-basis-point H1 buffer provides substantial safety margin. Risks: US demand weakness, Chinese Cognac tariffs, macro slowdown. Supporting: Rémy Martin premiumization strategy, confirmed guidance, strong Q2 momentum.
🍾 Beverages
✦ AI
After the record of 322 million bottles (2021), Champagne shipments are in structural decline: ~319 million in 2022, ~299 million in 2023 (CIVC). Continued luxury weakness in China (export volume –27% YoY H1 2026), rising input costs, and saturated key markets (USA, France, UK) point to further contraction. At –5 to –7% p.a. decline (2022–2025 trend), 2026 volume would be approximately 262–271 million bottles — well below the 280 million threshold. No prediction market signal available. Confirmed via CIVC annual report or Reuters by January 31, 2027.
🍾 Beverages
✦ AI
Analyst consensus for Q3 2026: EPS 0.2998 USD (~0.30 USD) with revenue of 2.49 billion USD (MarketBeat / TradingView, as of October 2026). Monster Beverage has beaten EPS consensus in a majority of recent quarters and continues to benefit from international market expansion in the energy drink segment. No active Polymarket or Kalshi market found for this event; beat probability estimated at ~65% based on historical beat rate and current consensus positioning.